Bio-based specialty chemicals company Lygos has won US$13 million in Series A funding from investors including IA Ventures and OS Fund. The California-based firm uses engineered microbes with sugar and water to create high-value specialty chemicals, in a cleaner, greener alternative process to the dirty petrochemical industry. The funds raised will be used to continue "building our team, our manufacturing and QC infrastructure", said Eric Steen, co-founder and CEO of Lygos.
Bio-based specialty chemicals company Lygos has won $13m in Series A funding from investors including IA Ventures and OS Fund. The California-based firm uses engineered microbes with sugar and water to create high-value specialty chemicals, in a cleaner, greener alternative process to the dirty petrochemical industry. The funds raised will be used to continue "building our team, our manufacturing and QC infrastructure", said Eric Steen, co-founder and CEO of Lygos.